A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The primary aim of this project is to examine whether administration of D-Cycloserine (DCS),
a partial N-methyl-D-aspartate (NMDA) receptor agonist that has been shown to facilitate fear
extinction, enhances the therapeutic benefit of exposure-based cognitive behavioral therapy
(CBT) in OEF/OIF veterans with PTSD.
Phase:
N/A
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development